Skip to main content

Market Overview

Evogene Ltd. (NYSE: EVGN)

3.65 -0.10 (-2.67%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
Pre-Market
EPS:
REV:




Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
-0.17
316K



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.24
75K

300K
-0.17
333K

11%
Q4 2020
Pre-Market
EPS:
REV:
-0.24
116K

-0.25
351K

Q3 2020
Pre-Market
EPS:
REV:
-0.16
97K

1.9M
-0.17
316K

-83.37%
Q2 2020
Pre-Market
EPS:
REV:
-0.16
192K

1.9M
-0.16
298K

-84.32%
Q1 2020
Pre-Market
EPS:
REV:
-0.15
348K

1.9M
-0.24
75K

-96.05%
Q4 2019
Pre-Market
EPS:
REV:
-0.23
635K

1.9M
-0.24
116K

-93.89%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!